141 related articles for article (PubMed ID: 30464509)
1. Protein tyrosine phosphatase L1 inhibits high-grade serous ovarian carcinoma progression by targeting IκBα.
Wang Y; Li M; Huang T; Li J
Onco Targets Ther; 2018; 11():7603-7612. PubMed ID: 30464509
[TBL] [Abstract][Full Text] [Related]
2. Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer.
Révillion F; Puech C; Rabenoelina F; Chalbos D; Peyrat JP; Freiss G
Int J Cancer; 2009 Feb; 124(3):638-43. PubMed ID: 19004008
[TBL] [Abstract][Full Text] [Related]
3. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
[TBL] [Abstract][Full Text] [Related]
4. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
5. SOCS7/HuR/FOXM1 signaling axis inhibited high-grade serous ovarian carcinoma progression.
Du Y; Xu X; Lv S; Liu H; Sun H; Wu J
J Exp Clin Cancer Res; 2022 May; 41(1):185. PubMed ID: 35624501
[TBL] [Abstract][Full Text] [Related]
6. High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcome.
D'Hondt V; Lacroix-Triki M; Jarlier M; Boissiere-Michot F; Puech C; Coopman P; Katsaros D; Freiss G
Oncotarget; 2017 Nov; 8(56):95662-95673. PubMed ID: 29221157
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase L1 represses endothelial-mesenchymal transition by inhibiting IL-1β/NF-κB/Snail signaling.
Wei XM; Wumaier G; Zhu N; Dong L; Li CW; Xia JW; Zhang YZ; Zhang P; Zhang XJ; Zhang YY; Li SQ
Acta Pharmacol Sin; 2020 Aug; 41(8):1102-1110. PubMed ID: 32152438
[TBL] [Abstract][Full Text] [Related]
8. MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3.
Zhang L; Zhang Y; Wang S; Tao L; Pang L; Fu R; Fu Y; Liang W; Li F; Jia W
Am J Transl Res; 2020; 12(3):875-888. PubMed ID: 32269720
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket.
Villa F; Deak M; Bloomberg GB; Alessi DR; van Aalten DM
J Biol Chem; 2005 Mar; 280(9):8180-7. PubMed ID: 15611135
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.
Wang J; Li S; Zhang X; Zhu N; Yiminniyaze R; Dong L; Li C; Gulinuer W; Xia J; Li J; Zhou D; Liu X; Zhang Y; Zhang Y; Li S
Thorac Cancer; 2022 Nov; 13(21):3042-3051. PubMed ID: 36193770
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
[TBL] [Abstract][Full Text] [Related]
12. PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells.
Castilla C; Chinchón D; Medina R; Torrubia FJ; Japón MA; Sáez C
Cell Death Dis; 2013 Apr; 4(4):e576. PubMed ID: 23559010
[TBL] [Abstract][Full Text] [Related]
13. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of tumor PD-L1 expression combined with CD8
Wang Q; Lou W; Di W; Wu X
Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W
Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656
[TBL] [Abstract][Full Text] [Related]
16. Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells.
Bompard G; Puech C; Prébois C; Vignon F; Freiss G
J Biol Chem; 2002 Dec; 277(49):47861-9. PubMed ID: 12354757
[TBL] [Abstract][Full Text] [Related]
17. GINS Complex Subunit 2 Facilitates Gastric Adenocarcinoma Proliferation and Indicates Poor Prognosis.
Feng H; Zeng J; Gao L; Zhou Z; Wang L
Tohoku J Exp Med; 2021 Oct; 255(2):111-121. PubMed ID: 34629365
[TBL] [Abstract][Full Text] [Related]
18. PTPN13/PTPL1: an important regulator of tumor aggressiveness.
Freiss G; Chalbos D
Anticancer Agents Med Chem; 2011 Jan; 11(1):78-88. PubMed ID: 21235435
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer.
Zhang Y; Liu J; Raj-Kumar PK; Sturtz LA; Praveen-Kumar A; Yang HH; Lee MP; Fantacone-Campbell JL; Hooke JA; Kovatich AJ; Shriver CD; Hu H
Breast Cancer Res Treat; 2020 Dec; 184(3):689-698. PubMed ID: 32880016
[TBL] [Abstract][Full Text] [Related]
20. [Expression and Significance of PTPL1 in Hematological Malignancies].
Wang WM; Wang J; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1744-7. PubMed ID: 25543508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
